Biopure Hemopure Advisory Committee For Hemorrhagic Shock Expected By September
This article was originally published in The Pink Sheet Daily
Executive Summary
The FDA committee would likely discuss circumstances under which the agency could lift a clinical hold that has been on the Hemopure trial since the IND was submitted in June 2005.